Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709204455/en/
Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen's RenMice® fully human antibody platform. Building on this established collaboration, the new agreement expands the partnership into antibody license, further strengthening the strategic relationship between the two companies.
Dr. Yuelei Shen, President and CEO of Biocytogen, said, 'BeOne Medicines is a global leader in drug development, and we are thrilled to enter into this strategic collaboration. The antibodies licensed under this agreement were discovered using our proprietary RenMice® fully human antibody platform, highlighting our ability to empower partners in driving innovative drug discovery. We look forward to seeing these promising molecules progress rapidly into the clinic and ultimately bring transformative treatment options to patients worldwide.'
Under the terms of the agreement, Biocytogen will receive an upfront payment from BeOne Medicines. In addition, Biocytogen is eligible to receive development and regulatory milestone payments, commercial milestone payments, and tiered royaltiesbased on future net sales of licensed products.
About Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMab™/ RenLite®/ RenNano®/ RenTCR-mimic™) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >1,000,000 fully human antibody sequences against over 1000 targets for worldwide collaboration. As of December 31, 2024, approximately 200 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and over 50 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco, San Diego), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250709204455/en/
Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
19 minutes ago
- Business Upturn
XPENG and the Volkswagen Group Announce Entry into Agreement on Expanding E/E Architecture Technical Collaboration
The industry-leading Electrical/Electronic architecture ('E/E Architecture') jointly developed by both parties will be not only integrated into Volkswagen's electric vehicle platforms, but also deployed across its ICE and PHEV platforms in China, thereby significantly expanding the strategic technical collaboration to broader markets. This Expanded Technical Collaboration on E/E Architecture marks another milestone in the long-term strategic partnership between XPENG and Volkswagen Group, driving continuous strategic value creation for both parties. GUANGZHOU, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — XPeng Inc. ('XPENG' or the 'Company', NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle company, and the Volkswagen Group, one of the world's leading automobile manufacturers, are pleased to announce that, following the execution of Master Agreement on E/E Architecture Technical Collaboration on July 22, 2024, XPENG and the Volkswagen Group have accelerated the joint development of the industry-leading E/E Architecture at 'China Speed' and achieved key milestones. Based on the shared strategic objective to expand the application scope of the E/E Architecture within the Volkswagen Group and realize cross-platform and cross-powertrain platformization, both parties have entered into an Agreement on Expanding E/E Architecture Technical Collaboration ('Expanded Technical Collaboration'). The signing of this agreement marks that the E/E Architecture will be not only integrated into Volkswagen's electric vehicle platforms, but also deployed across its ICE (Internal Combustion Engine) and PHEV (Plug-in Hybrid Electric Vehicle) platforms in China, thereby significantly expanding the strategic technical collaboration to broader markets. The Expanded Technical Collaboration will further accelerate the Volkswagen Group's software-defined vehicle strategy execution and enhance its global competitiveness. Such cross-platform and cross-powertrain platformization of the E/E Architecture will enable the Volkswagen Group to achieve faster software iteration and Over-the-Air ('OTA') updates, and significantly shorten vehicle development cycle. Adhering to rigorous platform-oriented design philosophy, the joint R&D teams have designed and validated that the E/E Architecture developed for electric vehicle platforms can also be adapted to ICE and PHEV platforms. This technical solution represents a major milestone in joint technical collaboration, demonstrating the synergy and strategic value of the long-term partnership between both parties. The Expanded Technical Collaboration will significantly expand the scale of vehicles equipped with this industry leading E/E Architecture in China market, enabling the Volkswagen Group to realize significant platform-driven economies of scale and enhanced product competitiveness. 'The Expanded Technical Collaboration marks a significant milestone in the ongoing strategic collaboration between XPENG and the Volkswagen Group, following the signing of the Master Agreement on E/E Architecture Technical Collaboration on July 22, 2024. This Expanded Technical Collaboration not only underscores the mutual trust in our long-term strategic partnership but also highlights our commitment to and vision for continuous innovation in smart electric vehicle technologies,' said Mr. Xiaopeng He, Chairman and CEO of XPENG. Ralf Brandstätter, CEO of Volkswagen Group China and Member of the Board of Management of Volkswagen AG for China: 'We do not confine technological excellence to a single powertrain type. Our brands are committed to delivering the most advanced solutions for customers in every segment. By extending the China Electronic Architecture to our robust combustion engine fleet, we are strengthening our technological leadership in the conventional powertrain sector. At the same time, we are systematically reducing our cost base, enabling us to continue offering highly attractive choices to customers in China's intensely competitive automotive market. This will reinforce the company's economic resilience, create capacity for targeted investment in cutting-edge innovations, and advance our journey toward fully connected, intelligent electric mobility.' About XPENG XPENG is a leading Chinese Smart EV company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to become a smart technology company trusted and loved by users worldwide. In order to optimize its customers' mobility experience, XPENG develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including the powertrain and the electrical/electronic architecture. XPENG is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Silicon Valley and San Diego. The Company's Smart EVs are mainly manufactured at its plants in Zhaoqing and Guangzhou, Guangdong province. For more information, please visit About the Volkswagen Group The Volkswagen Group is one of the world's leading car makers, headquartered in Wolfsburg, Germany. It operates globally, with 115 production facilities in 17 European countries and 10 countries in the Americas, Asia and Africa. With around 680,000 employees worldwide. The Group's vehicles are sold in over 150 countries. With an unrivalled portfolio of strong global brands, leading technologies at scale, innovative ideas to tap into future profit pools and an entrepreneurial leadership team, the Volkswagen Group is committed to shaping the future of mobility through investments in electric and autonomous driving vehicles, digitalization and sustainability. In 2024, the total number of vehicles delivered to customers by the Group globally was 9.0 million (2023: 9.2 million). Group sales revenue in 2024 totaled EUR 324.6 billion (2023: EUR 322.3 billion). The operating result before special items in 2024 amounted to EUR 19.1 billion (2023: EUR 22.5 billion). Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'will,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates' and similar statements. Statements that are not historical facts, including statements about XPENG's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: XPENG's goals and strategies; XPENG's expansion plans; XPENG's future business development, financial condition and results of operations; the trends in, and size of, China's EV market; XPENG's expectations regarding demand for, and market acceptance of, its products and services; XPENG's expectations regarding its relationships with customers, contract manufacturers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in XPENG's filings with the SEC. All information provided in this press release is as of the date of this press release, and XPENG does not undertake any obligation to update any forward-looking statement, except as required under applicable law. Contacts: For Investor Enquiries: IR DepartmentXPeng Inc. Email: [email protected]
Business Upturn
19 minutes ago
- Business Upturn
Liquid I.V. Debuts Innovative New Sugar-Free Hydration Multiplier in Canada
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Today, Liquid I.V., the number one selling powdered hydration brand in Canada1 announced the expansion of their product portfolio with the launch of the new Sugar-Free Hydration Multiplier. Available in the delicious and refreshing White Peach flavour, this launch marks Liquid I.V.'s most significant innovation in the market to date and is the brand's first sugar-free offering for Canadians. 'Sugar-free marks a bold step forward for Liquid I.V., cementing our place not only as leaders but innovators of hydration solutions,' said Anusha Babbar, Senior Vice President of International, Unilever Wellbeing. 'Canadians have shown great love to Liquid I.V. these past two years in market, so we're thrilled to be expanding our Canadian offering in the wellness category to meet their demands for a sugar-free option.' Liquid I.V. entered Canada in 2023, marking its first expansion beyond the U.S., and quickly established itself as a leading provider of powdered hydration. Yet, fans of the electrolyte beverage have been vocal about the need for a sugar-free option to meet their lifestyle needs. Today, Liquid I.V. responds to the demand with a first-of-its-kind formula that is scientifically formulated to restore electrolyte imbalances that occur through performance, heat, travel and adventure, without the sugar. 'Sugar is often used as a key ingredient in electrolyte beverages for hydration support. We clinically tested countless sugar-free formulations to ensure that we weren't just ticking a box, but creating a formula backed by science that truly supported functional hydration,' said Lori Lauersen, Senior Vice President R&D, Unilever Wellbeing. 'What we developed was an amino acid blend available in our Sugar-Free Hydration Multiplier, all delivered within a delightful peach flavoured beverage.' Liquid I.V. Sugar-Free White Peach Hydration Multiplier delivers smart 0 sugar hydration that supports consumers in maintaining their wellness goals. It contains: 0g sugar 6 essential vitamins and minerals Blend of amino acids No artificial flavours or colours 100% + daily value of essential B vitamins (B3, B5, B12) To enjoy, simply pour one easy-to-open packet into 500ml of water, mix or shake, and hydrate. Its convenient single-serve, travel-friendly packets are easy to enjoy on the go. Liquid I.V. Sugar-Free White Peach is currently available at Costco Canada and will be available on later this month. About Liquid I.V.® Liquid I.V.® is a wellness company based in Los Angeles, CA. We believe hydration is the bedrock of wellness so our products are designed to deliver hydration and additional benefits with delicious flavour. The product line features great-tasting, non-GMO electrolyte drink mixes for enhanced hydration. As a purpose-driven brand, giving back is at the core of Liquid I.V.'s DNA, to date we've donated over 71 million servings to people in need around the globe. Liquid I.V.® contributes over 1% of brand revenue to our Impact Program focused on Clean Water Access & Hydration Aid. Liquid I.V.® provides grants to organizations that expand clean water access. We are committed to our goal of donating 150 million Liquid I.V.® sticks over the next 10 years. Liquid I.V. is available in-store at Costco, Walmart, and other national retailers, and online on To learn more, visit and follow @liquidivcanada on Instagram, TikTok and Facebook. For more information, please contact:Amanda FederchukKetchum, on behalf of Liquid I.V. [email protected] 416-505-0517
Business Wire
an hour ago
- Business Wire
ICE Index Serves as Benchmark for Taiwan's First Multi-Asset ETF Issued by KGI SITE
TAIPEI, Taiwan & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced that KGI Securities Investment Trust Co., LTD (KGI SITE) has launched the KGI US Top Balanced ETF, Taiwan's first multi-asset exchange-traded fund (ETF), benchmarked to the NYSE TPEx 70-30 Equity Top 10 N-Listed & Treasury 3-10 Year Balanced Index. 'This innovative index is a blend of the large cap, technology-focused equities in the NYSE® Top 10 N-Listed Index and the treasury bonds within the ICE U.S. Treasury 3-10 Year Bond Index, offering a balanced and diversified structure for users,' said Christy Chan, Head of Client Development in APAC at ICE. 'The launch of the KGI US Top Balanced ETF marks a significant milestone as Taiwan's first multi-asset ETF and the inaugural product arising out of an index collaboration between ICE and the Taipei Exchange.' The index co-branding agreement between ICE and the Taipei Exchange (TPEx) was announced in November 2024. ICE leveraged its multi-asset class customized index capabilities to develop the index, which rebalances monthly to a 70% allocation to ten large cap, technology-focused equities, along with a 30% allocation to U.S. Treasury bonds with maturities between three and ten years, creating a rules-based, multi-asset benchmark. 'We're pleased to introduce the KGI US Top Balanced ETF, a core investment product designed to support long-term retirement planning,' said Albert Ding, the Chairman of KGI SITE. 'This ETF not only provides investors with a strategic tool for building financial security, but also embodies KGI SITE's enduring commitment to walking alongside our clients in realizing a prosperous future together.' As interest in multi-asset strategies continues to grow globally, ICE is well-positioned to provide customers with prepackaged solutions across all asset classes to meet their evolving needs. By utilizing the ICE Custom Index tool, customers can prototype and backtest custom indices based on existing ICE indices to explore potential tailored solutions that address their specific requirements throughout the region. For more information about ICE's Index solutions, visit: About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE: ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-critical workflow tools that increase transparency and efficiency. ICE's futures, equity, and options exchanges -- including the New York Stock Exchange -- and clearing houses help people invest, raise capital and manage risk. We offer some of the world's largest markets to trade and clear energy and environmental products. Our fixed income, data services and execution capabilities provide information, analytics and platforms that help our customers streamline processes and capitalize on opportunities. At ICE Mortgage Technology, we are transforming U.S. housing finance, from initial consumer engagement through loan production, closing, registration and the long-term servicing relationship. Together, ICE transforms, streamlines, and automates industries to connect our customers to opportunity. Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange. Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located here. Key Information Documents for certain products covered by the EU Packaged Retail and Insurance-based Investment Products Regulation can be accessed on the relevant exchange website under the heading 'Key Information Documents (KIDS).' Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Statements in this press release regarding ICE's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE's Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on February 6, 2025. ICE Data Indices, LLC is the administrator of the NYSE TPEx 70-30 Equity Top 10 N-Listed & Treasury 3-10 Year Balanced Index, the NYSE® Top 10 N-Listed Index, and the ICE U.S. Treasury 3-10 Year Bond Index. Additional important information regarding these indices, including methodologies, limitations, and disclaimers, can be found at Neither any investment product mentioned herein (the 'Product'), nor the issuer of such Product, as applicable, are sponsored, endorsed, sold or promoted by ICE, its affiliates or their third-party suppliers ('ICE and its Suppliers'). ICE and its Suppliers make no representations or warranties regarding the advisability of investing in securities generally or in any investment product based on an index. Past performance of an index is not an indicator of or a guarantee of future results. Category: Fixed Income and Data Services
